BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37482411)

  • 1. Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation - ANAFIE Registry Sub-Analysis.
    Akao M; Inoue H; Yamashita T; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Shimizu W
    Circ J; 2023 Nov; 87(12):1765-1774. PubMed ID: 37482411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    J Cardiol; 2023 May; 81(5):441-449. PubMed ID: 36427691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant therapy and home blood pressure-associated risk for stroke/bleeding events in elderly patients with non-valvular atrial fibrillation: the sub-cohort study of ANAFIE registry.
    Kario K; Hasebe N; Okumura K; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    Hypertens Res; 2023 Dec; 46(12):2575-2582. PubMed ID: 37433904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation - Substudy of the ANAFIE Registry.
    Ikeda T; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    Circ J; 2022 Jan; 86(2):202-210. PubMed ID: 34853279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    Miyazaki S; Miyauchi K; Hayashi H; Yamashiro K; Tanaka R; Nishizaki Y; Nojiri S; Suwa S; Sumiyoshi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
    J Cardiol; 2022 Jul; 80(1):41-48. PubMed ID: 35346556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Polypharmacy on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation - A Sub-Analysis of the ANAFIE Registry.
    Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    Circ J; 2022 Dec; 87(1):6-16. PubMed ID: 35858804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry.
    Yamashita T; Suzuki S; Inoue H; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):202-213. PubMed ID: 33822030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glycated hemoglobin on 2-year clinical outcomes in elderly patients with atrial fibrillation: sub-analysis of ANAFIE Registry, a large observational study.
    Terauchi Y; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Shimizu W
    Cardiovasc Diabetol; 2023 Jul; 22(1):175. PubMed ID: 37438827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial Fibrillation.
    Wakamatsu Y; Nagashima K; Watanabe R; Arai M; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Hayashi H; Iwasaki YK; Shimizu W; Nakajima I; Harada T; Koyama J; Okumura K; Tokuda M; Yamane T; Tanimoto K; Momiyama Y; Nonoguchi N; Soejima K; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Yazaki Y; Satomi K; Watari Y; Okumura Y
    Int Heart J; 2020 Nov; 61(6):1165-1173. PubMed ID: 33191353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background characteristics and anticoagulant usage patterns of elderly non-valvular atrial fibrillation patients in the ANAFIE registry: a prospective, multicentre, observational cohort study in Japan.
    Yasaka M; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    BMJ Open; 2021 Mar; 11(3):e044501. PubMed ID: 34006033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.
    Murata N; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itoh S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Circ J; 2019 Mar; 83(4):727-735. PubMed ID: 30726797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary events in elderly patients with non-valvular atrial fibrillation: a prespecified sub-analysis of the ANAFIE registry.
    Nakamura M; Inoue H; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Yasaka M; Yamaguchi T; Teramukai S; Morishima Y; Fukuzawa M; Takita A; Hirayama A
    Cardiovasc Interv Ther; 2024 Apr; 39(2):145-155. PubMed ID: 38349574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotypes of older adults with non-valvular atrial fibrillation not treated with oral anticoagulants by hierarchical cluster analysis in the ANAFIE Registry.
    Suzuki S; Yamashita T; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
    PLoS One; 2023; 18(2):e0280753. PubMed ID: 36753467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose of Direct Oral Anticoagulants and Adverse Outcomes in Asia.
    Ohno J; Sotomi Y; Hirata A; Sakata Y; Hirayama A; Higuchi Y
    Am J Cardiol; 2021 Jan; 139():50-56. PubMed ID: 33065084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry.
    Navarro-Almenzar B; Cerezo-Manchado JJ; Caro-Martinez C; García-Candel F; Flores Blanco PJ; Ruiz GE; Andreu Cayuelas JM; Montoya FA; Cascales A; Lova Navarro A; García Alberola A; Andrés Pascual Figal D; Bailen Lorenzo JL; Manzano-Fernández S
    Curr Med Res Opin; 2019 Dec; 35(12):2035-2041. PubMed ID: 31335222
    [No Abstract]   [Full Text] [Related]  

  • 17. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
    Mizokami Y; Yamamoto T; Atarashi H; Yamashita T; Akao M; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H
    PLoS One; 2020; 15(11):e0240859. PubMed ID: 33151969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and anticoagulation therapy in elderly non-valvular atrial fibrillation and heart failure patients.
    Ikeda S; Hiasa KI; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Suzuki S; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Tsutsui H
    ESC Heart Fail; 2024 Apr; 11(2):902-913. PubMed ID: 38213104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.